PortfoliosLab logoPortfoliosLab logo
ORCL vs. LLY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ORCL vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Oracle Corporation (ORCL) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ORCL achieves a -26.03% return, which is significantly lower than LLY's 11.27% return. Over the past 10 years, ORCL has underperformed LLY with an annualized return of 15.03%, while LLY has yielded a comparatively higher 33.32% annualized return.


ORCL

1D
-2.22%
1M
-42.25%
YTD
-26.03%
6M
-26.03%
1Y
-33.90%
3Y*
7.62%
5Y*
13.38%
10Y*
15.03%

LLY

1D
-0.64%
1M
10.12%
YTD
11.27%
6M
11.27%
1Y
54.68%
3Y*
37.43%
5Y*
39.80%
10Y*
33.32%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ORCL vs. LLY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ORCL
Oracle Corporation
-26.03%18.13%59.99%30.94%-4.65%36.89%24.25%19.34%-2.97%24.94%
LLY
Eli Lilly and Company
11.27%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%

Correlation

The correlation between ORCL and LLY is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (10Y)
Calculated over the trailing 10-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Mar 12, 1986

0.25

The correlation between ORCL and LLY shifts across timeframes, from -0.04 (1 year) to 0.26 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ORCL:

$415.39B

LLY:

$1.07T

EPS

ORCL:

$5.86

LLY:

$28.16

PE Ratio

ORCL:

24.31

LLY:

42.32

PEG Ratio

ORCL:

1.00

LLY:

0.85

PS Ratio

ORCL:

6.17

LLY:

14.81

PB Ratio

ORCL:

9.65

LLY:

34.22

Total Revenue (TTM)

ORCL:

$67.36B

LLY:

$72.25B

Gross Profit (TTM)

ORCL:

$79.58B

LLY:

$59.75B

EBITDA (TTM)

ORCL:

$6.20B

LLY:

$32.97B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ORCL vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ORCL
ORCL Risk / Return Rank: 2222
Overall Rank
ORCL Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
ORCL Sortino Ratio Rank: 2020
Sortino Ratio Rank
ORCL Omega Ratio Rank: 2222
Omega Ratio Rank
ORCL Calmar Ratio Rank: 2222
Calmar Ratio Rank
ORCL Martin Ratio Rank: 2525
Martin Ratio Rank

LLY
LLY Risk / Return Rank: 8080
Overall Rank
LLY Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 7878
Sortino Ratio Rank
LLY Omega Ratio Rank: 7979
Omega Ratio Rank
LLY Calmar Ratio Rank: 8181
Calmar Ratio Rank
LLY Martin Ratio Rank: 8181
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ORCL vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Oracle Corporation (ORCL) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ORCLLLYDifference
Sharpe ratioReturn per unit of total volatility

-1.95

Sortino ratioReturn per unit of downside risk

-2.59

Omega ratioGain probability vs. loss probability

0.94

1.27

-0.34

Calmar ratioReturn relative to maximum drawdown

-0.58

2.37

-2.95

Martin ratioReturn relative to average drawdown

-0.92

5.92

-6.84

ORCL vs. LLY - Sharpe Ratio Comparison

The current ORCL Sharpe Ratio is -0.53, which is lower than the LLY Sharpe Ratio of 1.43. The chart below compares the historical Sharpe Ratios of ORCL and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ORCL vs. LLY - Drawdown Comparison

The maximum ORCL drawdown since its inception was -84.19%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for ORCL and LLY.


Loading charts...

Drawdown Indicators


ORCLLLYDifference

Max Drawdown

Largest peak-to-trough decline

-84.19%

-68.24%

-15.95%

Max Drawdown (1Y)

Largest decline over 1 year

-58.25%

-23.18%

-35.07%

Max Drawdown (3Y)

Largest decline over 3 years

-58.25%

-34.48%

-23.77%

Max Drawdown (5Y)

Largest decline over 5 years

-58.25%

-34.48%

-23.77%

Max Drawdown (10Y)

Largest decline over 10 years

-58.25%

-34.48%

-23.77%

Current Drawdown

Current decline from peak

-56.01%

-3.11%

-52.90%

Average Drawdown

Average peak-to-trough decline

-29.13%

-19.19%

-9.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

37.02%

9.26%

+27.76%

Volatility

ORCL vs. LLY - Volatility Comparison

Oracle Corporation (ORCL) has a higher volatility of 15.70% compared to Eli Lilly and Company (LLY) at 9.95%. This indicates that ORCL's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ORCLLLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.70%

9.95%

+5.75%

Volatility (6M)

Calculated over the trailing 6-month period

42.02%

27.88%

+14.14%

Volatility (1Y)

Calculated over the trailing 1-year period

64.71%

38.47%

+26.24%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

42.40%

32.47%

+9.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.26%

30.27%

+4.99%

Dividends

ORCL vs. LLY - Dividend Comparison

ORCL's dividend yield for the trailing twelve months is around 1.97%, more than LLY's 0.54% yield.


PositionTTM20252024202320222021202020192018201720162015
LLY
Eli Lilly and Company
0.54%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%
ORCL
Oracle Corporation
1.97%0.97%0.96%1.44%1.57%1.38%1.48%1.72%1.68%1.52%1.56%1.56%

Financials

ORCL vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Oracle Corporation and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


6.00B8.00B10.00B12.00B14.00B16.00B18.00B20.00B20222023202420252026
19.18B
19.80B
(ORCL) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ORCL and LLY have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ORCL has higher volatility (15.70%) compared to LLY (9.95%). In terms of maximum drawdown, ORCL dropped -84.19% vs LLY's -68.24%.

LLY currently has the higher Sharpe Ratio (1.43 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ORCL and LLY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer